Phase I Study of S64315 Administred Intravenously in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome
Status:
Completed
Trial end date:
2020-05-11
Target enrollment:
Participant gender:
Summary
The CL1-64315-001 study is a phase I, international, multicentre, open-label, non-randomised,
non-comparative study. This study is designed in two parts: one part for dose escalation, one
part for dose expansion.